Voice of America - October 8, 2007
Nick Wadhams
Nairobi

An Indian drug company has opened a factory in Uganda that will produce generic HIV/AIDS drugs in what local officials are praising as a crucial step to fight the pandemic across East Africa. Nick Wadhams has the story for VOA from Nairobi.

The pharmaceutical giant Cipla, one of the world's leading generic-drug makers, is partnering with the Ugandan-based Quality Chemicals company to manufacture the AIDS and malaria drugs in Uganda.

It is part of a larger push across the continent to produce the generic versions of expensive drugs at home. Ugandan officials say that less than half of the people in the country who need the drugs get them.

A spokesman for Uganda's health ministry, Dr. Sam Okware, says the presence of the factory will allow the government to reach more people who need anti-retroviral treatment. The government will not have to spend money importing drugs and will face fewer shortages in drug stockpiles.

"Actually it is long overdue because you see these are generic drugs. This is epicenter of HIV/AIDS, East and Central Africa are the epicenter, so it is very welcome. We are very happy as a country," he said. "I expect the quality of life of people living with HIV to improve, I expect now the government to be able to buy more drugs than before because now the drugs are available locally so the cost of transport will not be there. I also expect many of the people living with HIV/AIDS now to access this drug directly, not through the health-care system, through the private system."

Uganda has been a rare African AIDS success story, cutting its infection rates from about 15 percent in the early 1990s to five-percent in 2001. But recent statistics suggest that HIV/AIDS is again on the rise in Uganda.

The producers of generic drugs have recently had trouble keeping up with the latest developments because new Indian patent laws have made it more difficult for them to copy the most up-to-date drugs.

Okware says the new plant will be challenged to keep pace as new drugs are brought to market. The factory is expected to begin producing AIDS and malaria drugs in the next few months.

"The only other fear we have is that as we move forward there may be newer drugs, which are coming and it is important that they integrate the new discoveries in what is existing right now," said Okware. "The whole science of HIV/AIDS, especially drugs, is always evolving, so we need to hope that they will be able to incorporate new remedies into their current plan."

Ugandan President Yoweri Museveni has been an outspoken critic of some of the major drug companies and has demanded they sell their drugs cheaply. The average Ugandan makes about $2 a day, far too little to pay the full cost of anti-retroviral treatment.

071008
VA071004

Copyright © 2007 - Voice of America. You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .